Preventing Acute Atrophied Muscles by Therapeutic Magnetic Stimulation – RT-PCR study –

 

Sakuraba T 1, Shimada Y 2, Kawatani M 3, Takahashi S 1, Matsunaga T 2,
Misawa A 1, Ito H 1, Aizawa T 1, Sato M 2, Chida S 2

 

1 Department of Orthopaedic Surgery, Akita University School of Medicine, Japan

2 Rehabilitation Division of Akita University Hospital, Japan,

3 Department of Physiology, Akita University School of Medicine, Japan

 

Email: Sakulaba@doc.med.akita-u.ac.jp


Abstract

Recent progress of functional magnetic stimulation  (FMS) has been also applied to stimulate many types of nervous systems. This study assessed the potential application and effectiveness of FMS for preventing the skeletal muscle atrophy in adult rats.  Nine Wister male rats were examined and assigned to three groups; control group, non-stimulated group, and stimulation group.  FMS using the magnetic coil was performed by placing a round magnetic coil  (MC) at L3-L5 at 20Hz frequency for 60min/day, for up to 10 days. The Soleus, TA and EDL muscles of rats were used.   A reverse Transcriptase-polymerase chain reaction was established to determine absolute amounts of mRNAs specific to four myosin heavy chain isoforms. [MHC IIb, MHC IId(x), MHC IIa, and MHC Iβ] in rat hindlimb muscle during contractile activity by Magnetic Stimulation. In the soleus muscle, MHC Iβ mRNA and MHC IIa mRNA of rats in stimulated group were steeply increased, and of atrophied group were decreased. In fast contractile muscle, each type of muscle fibers were not significantly changed, however, relative to control group, mRNA of MHC Iβ and MHC IIa were tend to increase by magnetic stimulation.

These results suggest that magnetic stimulation for acute atrophied muscles is useful for reducing the muscle atrophy as Therapeutic electric stimulation  (TES) which  has been performed to increase muscle force, as well as prevent muscle atrophy.

 

1           Introduction

Functional magnetic stimulation (FMS) does not require surgery, thus avoiding complications associated with surgery or chronic implants, such as infection and haemorrhage [1]. The magnetic fields generated from the magnetic coil are able to pass through high-resistance structures such as bone, fat, and skin without harm to the body. FMS has been used effectively to stimulate the spinal nerves below the level of spinal cord injury (SCI) [3].

The implementability of using functional electrical stimulation (FES) [2] for muscle activation to restore gait in these patients has been demonstrated. This is possible because most of these patients have intact peripheral nerves below their level of injury that can be stimulated to provide muscle contractions. Therapeutic electrical stimulation (TES) [2] has been performed to increase muscle force, and to prevent muscle atrophy.

The purpose of this study is to evaluate the effects of magnetic stimulation in preventing acute muscle atrophy in rats.

 

2           Methods

Nine adult male Wister ST rats with an average body weight of 241g (range 216-267g) were used in these experiments. The animals were assigned to 3 groups: the control group (n=3); the stimulated group (n=3); and the non-stimulated group (n=3). The rats of stimulated and non-stimulated group were suspended by their tails through the silks.

A commercially available magnetic stimulator (Daiya Industry Co. Japan) was used for FMS and the average of diameter in magnetic coil (MC) was 30mm. This stimulator can generate the maximum field strength of 1.0 Tesla near the MC. The continuous stimulation parameters were set up to 750V (about 93% of maximum intensity of this system) and 20Hz. The MC was supported by an adjustable frame, and then it was possible to keep the centre of


Table 1: Primers for cDNA synthesis and polymerase chain reaction of MHC isoforms

 

   Isoform            Product Length           Primer Sequence                                                                                         Annealing Temperature (deg C)                  

  MHC Iβ           288bp                            Antisense                                                                                                      5’-GGGCTTCACAGGCATCCTTAG-3’         64

                                                                   Sense          5’-ACAGAGGAAGACAGGAAGAACCTAC-3’

   MHC IIa           310bp                            Antisense   5’-TAAATAGAATCACATGGGGACA-3’                            59

                             Sense                             5’-TATCCTCAGGCTTCAAGATTTG-3’

   MHC IIb           288bp                            Antisense  5’-TTGTGTGATTTCTTCTGTCACCT-3’                              59

                                                                   Sense          5’-CTGAGGAACAATCCAACGTC-3’

   MHC IId(x)      120bp                            Antisense  5’-TCCCAAAGTCGTAAGTACAAAATGG-3’                    55

                                                                   Sense          5’-CGCGAGGTTCACACCAAA-3’

   GAPDH           531bp                            Antisense   5’-CACGCCACAGCTTTCCAGA-3’                                       60

                                                                   Sense          5’-GCTGCCTTCTCTTGTGACAAA-3’                                                                                    .                                                   


 

the coil placed on L3-L5 beside the midline initially for lumbosacral stimulation, which was variable to obtain the maximal movement of their hindlimbs as an optimal stimulation (Fig 1). 

Figure 1:  The site of stimulation

 

This stimulation of the rats performed for 60min/day, for 10 days. Magnetic stimulation for the rats of the stimulated group was started 1 day after the operation. The day after the stimulation period ended, the soleus, tibialis anterior and extensor digitorum longus muscles of the rats were surgically removed from both legs, immersed in RNA later TM (TaKaRa BIOCHEMICALS) twelve hours.

The muscle samples were pulverized under liquid nitrogen and homogenized in cold ISOGEN (NIPPON GENE) (1.0ml). After homogenisation, proteins and insoluble material were removed by 10min of centrifugation at 4 deg C at 12.000g. Phase separation was performed using chloroform (0.25ml). Isopropanol (0.25ml) were used for RNA precipitation. Pellets were resuspended in 70% ethanol (1.0ml). RNA concentration was assessed spectrophotometrically.

1.0 μg of Total RNA were reverse-transcripbed using Avian Myoblastosis Virus reverse Transcriptase XL (Life Science) 0.25U/μl and Random 9mers 2.5μM in 30second, at 42 deg C. Polymerase Chain Reaction (PCR) were

 

performed using Takara TaqTM  polymerase (TAKARA) and the primers specific to MHC

IIb, MHC IId(x), MHC IIa, and MHC Iβ (Table 1) which were derived from published cDNA sequences. Depending on the initial amount of template, the number of cycles was determined to 28 cycles to allow product detection in the exponential range of amplification. PCR products were analyzed by agarose gel electrophoresis, aliquots (10.0μl) were loaded in a 1.5% agarose gel containing 0.5μg/ml ethisium bromide and separated in a 1X TBE buffer. Band intensity and area were calculated using NIH image. In order to investigate changes in transcript level of selected genes in MHC, we performed a semi-quantitative analysis of the message level of MHC genes. Each band intensity was calculated relative to the GAPDH control and expressed.

 

3           Results

Soleus. The mean relative amount of expression in each mRNA of MHC IIb, MHC IId(x), MHC IIa, and MHC Iβ to GAPDH were, respectively, 1.19, 1.12, 0.89 and 0.713 in control group, 0.563, 0.293,0.679 and 0.317 in non-stimulated group, 1.183, 1.51, 1.23 and 0.579 in stimulated group. The emerging rate of MHC Iβ and MHC IIa was remarkably changed. The emerging of non-stimulated groups was decreased and that of stimulated group was affected to increase.

Tibialis anterior. The mean relative amount of expression in each mRNA of MHC to GAPDH were, respectively, 0.438, 0.702, 0.782 and 0.337 in control group, 0.559, 0.677, 0.566 and 0.152 in non-stimulated group, 0.578, 0.883, 0.625 and 0.476 in stimulated group. For the TA we detected no differences among the experimental groups.

Extensor digitorum longus.  The mean relative amount of expression were, respectively, 0.648, 0.647, 0.665 and 0.348 in control group, 0.503, 0.591, 0.560 and 0.074 in non-stimulated group, 0.610, 0.450, 0.467 and 0.198 in stimulated group (Fig. 2). In the EDL, a decreasing in mRNA for non-stimulated group, and furthermore, only the increasing of emerging of MHCIβwas quantified. It would be said that the  data suggests the transition to slow muscle may occurred.

Figure 2: Distribution of MHC mRNA isoform in Soleus Muscle

 

4           Discussion and Conclusions

The present study was undertaken to investigate, in rat fast-twitch muscle exposed to stimulation, transitions in MHC expression at the mRNA level. Fast –twitch muscles can be transformed into slower contracting muscles by chronic low-frequency stimulation in order of MHC Iβ MHC IIa MHC IId(x) MHC IIb [4]. This process encompasses fast-to-slow fiber-type transitions concomitant with sequential changes in MHC composition. We were especially interested in the temporal patterns of induced transition in various MHC mRNA isoforms. Because sequences of the three fast MHC isoforms and MHC Iβ are available.

            The muscle atrophy in patients with SCI has been demonstrated a progressive decrease in the fiber diameter and changes in the fiber type distribution [4]. Once the muscle atrophy has occurred before the stimulation started and developed, then it require a longer period of time till the muscles return to near normal condition. In order to restore paralyzed muscles by TES, an increase in muscle fiber diameter is required. It is important to maintain muscle power by TES, as well as an increase in the size of muscle fiber. Our preliminary experiment suggests that magnetic stimulation of peripheral nerve might affect to prevent slow-to-fast transition. As a result of using magnetic stimulation, slow type of muscle growth in the acute phase of hindlimb suspension might outpaces fast muscle atrophy.  We believe that SCI patients can receive FMS earlier as long as the muscle atrophy does not develop.

 

References

[1]         Barker, A.T., Jalinous, R. & Freeston, I.L. Non-invasive stimulation of human motor cortex. Lance, i: 100-109, 1985.

[2]         Shimada, Y., Sato, K., Kagaya, H, et al.  Clinical Use of Percutaneous Intramuscular Electrodes for Functional Electrical Stimulation. Arch. Phys. Med. Rehabil., 77: 1014-1018, 1996.

[3]         Lin, VW, Hsiao, IN, Zhu, et al. Functional Magnetic Stimulation for conditioning of expiratory muscles in patients with spinal cord injury. Arch. Phys. Med. Rehabil., 82: 162-166, 2001.

[4]         Laurence S, Barbel G, Dirk P, et al. Changes in myosin heavy chain mRNA and protein isoforms in single fibers of unloaded rat soleus muscle. FEBS, 463: 15-18, 1999.